Minnesota Oncology is proud to announce our participation in the new Enhancing Oncology Model (EOM), a value-based care program from the Center for Medicare and Medicaid Innovation (CMMI).
Our commitment to high-quality patient outcomes and equal access to care at a sustainable cost is demonstrated through our participation in this and other value-based care models.
Launched on July 1, 2023, the five-year model test delivers towards the Biden-Harris Administration’s Cancer Moonshot goals, to decrease the cancer death rate by at least 50% over 25 years – saving and extending 4 million Americans lives – and to transform the experience of people who are touched by cancer and their families and caregivers.
As of June 27, 2023, 67 oncology physician group practices (PGPs) are participating in EOM. Across the 67 PGP participants, there are over 600 sites of care representing approximately 37 states nationally and over 3,000 unique practitioners.
The goal of EOM is to drive transformation in oncology care by preserving and enhancing the quality of care furnished to Medicare beneficiaries undergoing treatment for cancer while reducing Medicare program spending. EOM aims to improve quality and reduce costs through payment incentives and required participant redesign activities such as ensuring patients with Medicare have equitable access to navigation services and that providers discuss and develop an individualized care plan for their patients. Oncology practices that participate in EOM will take on financial and performance accountability for episodes of care surrounding systemic chemotherapy administration to patients with common cancer types.
As we implement the EOM and other value-based care models, we’re focused on doing more to help you better understand your illness, set expectations regarding side effects from treatment, helping you avoid unnecessary hospital and emergency room visits, providing access to enhanced services and screening for health-related social needs such as transportation and nutrition.
Share
Categories
Tags
Recent Posts
Bladder cancer is the fourth most common cancer diagnosed in men, and men are four times more likely than women to develop it.
In the United States, approximately 9,310 men are diagnosed with testicular cancer each year. It is the most common form of cancer in men between the ages of 15 and 35, and one of the most curable.
April is Esophageal Cancer Awareness Month, which makes this good time to learn the signs of esophageal cancer and what you can do to reduce your risk.